SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: S-1
Document Type: S-1
Date Filed: 2026-05-15
Accession Number: 0001213900-26-057939
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390026057939/ea0290954-s1_synergy.htm

Chunk 3 of 16
Word Count: 1485
Character Count: 9789

Document Content:

($176 billion in 2022) and growing (projected 8.6% CAGR covering eight years from 2022 through 2030) with an expanding range of functional benefits such as energy, hydration, cognition/focus, weight loss, gut health and immunity. Examples such as Celsius and Beyond Raw offer dual-benefit products that deliver fat burning plus energy while C4 Smart Energy and FocusAid deliver focus plus energy. Additionally, consumers are looking for not only refreshing drinks but health perks such as zero sugar and low-calorie drinks. This consumer shift in preferences towards more functional benefits can be seen in the evolution of the energy RTD category where originally competitors like Red Bull and Monster delivered conventional energy, then the category offered more performance energy products with added vitamins and amino acids in products such as Reign and C4 Performance to products with more natural energy characteristics and then to the dual-benefit energy products that we see today.

FOCUSfactor is well-positioned
to capitalize on the evolving energy RTD category (U.S. sales of $19.2 billion in 2023 and a CAGR of 6.3% from 2018 to 2023, according
to Euromonitor in December 2023) with its new focus plus energy RTD. We believe this represents a major growth opportunity, with our dual-benefit
RTD formula offering both focus and energy behind a 24+ year brand with strong heritage and awareness in the area of brain health. The
FOCUSfactor brand name clearly communicates the differentiation benefit of adding focus to energy. The FOCUSfactor formula does not have
to rely as heavily on caffeine as other brands such as Celsius, Bang, Reign and C4, as its formula is a balanced blend of vitamins, cognitive
nutrients and caffeine all in a zero sugar, low calorie, great-tasting drink. The brand also delivers a significant value relative to
many competitors. Additionally, FOCUSfactor has long-term relationships with large retailers where it has an established presence, which
will assist in market penetration for its RTD products. FOCUSfactor is looking to attract both existing consumers of supplement products
(typically customers over age 50) to RTDs as well as a younger demographic (aged 18-49).

FOCUSfactor has successfully
demonstrated the ability to leverage its existing retailer relationships to expand its RTDs. From March 2023 through August 2023, FOCUSfactor
conducted a five-month trial of its RTD products in 44 clubs of a warehouse club retailer throughout Texas with sales ranging from $550
per club per week to $2,382 per club per week. From April 2024 through July 2024, a second pilot was successfully completed at a major
Canadian club retailer throughout Canada with results ranging from C$378 per club per week to C$2,206 per club per week.

Our second marquee brand, Flat
Tummy, consists of a range of lifestyle and wellness products and accessories including tea, shakes, lollipops, supplements, apparel,
and exercise accessories. We also provide a Flat Tummy mobile app, which, as of December 31, 2025, had approximately 2.0 million unique
downloads and is intended as a tool to promote the Flat Tummy lifestyle centered around general wellness and health. Our Flat Tummy brand
consists of 13 SKUs and is sold direct to consumer through the Flat Tummy website and application, as well as through Amazon.com, Target.com
and iherb.com.

We also own six additional,
non-core brands. While we may elect to promote these brands and commercialize their products in the future, we have prioritized our
key brands, FOCUSfactor and Flat Tummy, and management is focused on the growth of these core products.

Our net revenues by brand for
the year ended December 31, 2025 are below:

In the United States,
the U.S. Food and Drug Administration (the “FDA”) has regulatory oversight over our FOCUSfactor and Flat Tummy products.
However, no formal FDA approval or registration is required because our products are classified as dietary supplements (most FOCUSfactor
products and some Flat Tummy products) or foods (some FOCUSfactor and Flat Tummy products).

In Canada, Health Canada (“HC”)
has oversight over our FOCUSfactor and Flat Tummy products. Our FOCUSfactor and Flat Tummy products are considered natural health products
by HC so they each have a natural product number that was assigned by HC upon its review and approval.

In Australia, FOCUSfactor products
are “Listed Medicines” that are regulated by the Therapeutic Goods Administration (“TGA”) and require an AUST
L (Australia Listed Medicine) number, which has been received for some SKUs. Flat Tummy products are classified as either Listed Medicines
or meal replacements. Listed Medicines are regulated by the TGA while meal replacements are regulated under the Australia New Zealand
Food Standards Code.

Our Competitive Strengths

We believe that we have attributes
that differentiate us from our competitors and provide us with significant competitive advantages. Our key competitive strengths include:

Well-Positioned in Growing Categories
Driven by Favorable Consumer Trends

An increased focus on health,
beauty and wellness by consumers has served as a tailwind for our brands. The nutritional supplement market has experienced significant
growth across a range of areas including immune health, brain health, heart health, sleep/stress, and overall nutrition and wellness as
a result of an aging population, increased obesity, pandemic concerns and a desire for more natural solutions and treatments over prescription
medication. We believe that we are well positioned to benefit from these favorable trends. The brain health segment is slated to grow
at 8% per year in the United States and 13% per year globally through 2030, according to Grand View Research. We believe our focus on
lifestyle products has also benefited from the growth and prevalence of social media.

Results Backed by Independent Study for
FOCUSfactor

We believe the FOCUSfactor
brand is strengthened by an independent clinical study to support the product claims for improved memory, concentration, and focus. FOCUSfactor
has been tested in a single-center, randomized, double-blind, placebo-controlled, parallel group study to evaluate its effect on memory,
concentration, and focus in healthy adults. The study was not a clinical trial conducted pursuant to an FDA-approved IND application,
and the FDA has not reviewed this study or evaluated these performance claims.

In this study, FOCUSfactor
was tested on its entire 52-ingredient formulation rather than testing one or two ingredients within a formulation. FOCUSfactor was shown
to provide a 44% increase in recall memory (an increase of 6.5 words compared to 4.5 words for the placebo group) after six weeks of use
versus placebo. This differentiates FOCUSfactor from other brain-health supplements and is a prime reason why FOCUSfactor has been placed
in premier retailers. This controlled study was conducted in healthy male and female subjects between the ages of 18 and 65 who were randomized
in a control group and a placebo group. Subjects were compensated for their participation. See the section entitled “Business — FOCUSfactor
Study” in the documents incorporated by reference into this prospectus for additional information.

Experienced Management Team with Proven
Track Record of Value Creation

Our executive team has a combined
90 years of experience in consumer marketing and distribution and has been instrumental in acquiring and building our core brands.
Management has exercised strong financial discipline in its acquisition strategy, with a focus on acquiring brands at attractive valuations.
For example, we acquired FOCUSfactor for approximately 3x trailing EBITDA. For the year ended December 31, 2025 and year ended
December 31, 2024, FOCUSfactor generated net revenue of $27.8 million and $30.7 million, respectively. Management’s
philosophy is to acquire promising brands that fit within our health, beauty and lifestyle offerings, and apply our marketing and distribution
strategies to develop brands to their full potential. We believe we are adept at identifying promising opportunities that build out and
complement our core brand portfolio.

Premier Retail Partners

Our premier retail partners
include Costco, Amazon.com, Walmart, Walgreens, BJ’s, and The Vitamin Shoppe and others. We sell products to these partners under
their standard arrangements, which do not include a term or duration as sales under each vendor agreement are generally made on a purchase
order basis. Our partners provide a platform to expand the breadth of our current offerings through product line extensions and new product
innovation. We continue to introduce new SKUs to our current retail partners, such as the addition of FOCUSfactor RTDs and vision products
to these retail partners and other channels. Additionally, the international footprint of certain of our various retail partners facilitates
our geographic expansion plans.

Scalable and Flexible Asset-Light Model
to Support Growth

Our focus is on brand management,
marketing, product development and distribution, and we utilize contract manufacturing partners in order to produce our various brand
offerings. The use of third-party manufacturing partners allows us to scale quickly, as we ensure that our partners have sufficient capacity
to meet our demand needs. We also maintain multiple relationships with different contract manufacturers, ensuring diversification of our
manufacturing base and reducing the likelihood of supply bottlenecks or deficits that could potentially slow our growth.

Our Growth Strategy

We intend to drive growth and
increased profitability in our business through these key elements of our strategy:

Broaden Media Advertising Strategy